Loading clinical trials...
Loading clinical trials...
Bone Fragility Evaluation by Dual X-Ray Absorptiometry (DXA) and CT-scan (vertebral Fracture and Scanographic Bone Attenuation Coefficient of the First Lumbar Vertebra SBAC-L1) in Obese Patients
This research will study the bone fragility in obese patients, on DXA and CT-scan, in a transversal study. The investigators want also to study the specific risk factors of bone fragility in these obese patients (relationship between body composition on whole body on DXA, fat mass and its location, lean mass, weight loss after surgery and SBAC-L1), to improve the bone screening.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Nancy university hosiptal
Vandœuvre-lès-Nancy, France
Start Date
February 23, 2020
Primary Completion Date
August 20, 2021
Completion Date
August 23, 2021
Last Updated
February 24, 2025
1,500
ACTUAL participants
DXA and CT-scan
DIAGNOSTIC_TEST
Lead Sponsor
Central Hospital, Nancy, France
Collaborators
NCT01143454
NCT07472881
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions